The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 12, 2023

Filed:

Aug. 22, 2022
Applicant:

Ammax Bio, Inc., Redwood City, CA (US);

Inventors:

Laman Alani, Menlo Park, CA (US);

Kirk William Johnson, Moraga, CA (US);

Michael Huang, Redwood City, CA (US);

Chung-Chiang Hsu, Los Altos Hills, CA (US);

Assignee:

AmMax Bio, Inc., Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); C07K 16/28 (2006.01); A61P 35/00 (2006.01); A61P 19/02 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0019 (2013.01); A61P 19/02 (2018.01); A61P 35/00 (2018.01); C07K 16/2866 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01);
Abstract

The present disclosure provides compositions and methods for intra-articular delivery of anti-CSF1R antibodies to a tissue that is impacted by a disease that is treatable with CSF1/CSF1R inhibition and/or that expresses CSF1R. It was conventional knowledge that the intra-articular dwell time of proteins in joints is typically a few hours or less. The present disclosure shows, however, that intra-articular delivery of an anti-CSF1R antibody can lead to sustained exposure and pharmacologic activity of the antibody in the joints far beyond a few hours, providing an effective means for targeted and extended delivery of the therapeutic agent.


Find Patent Forward Citations

Loading…